-
Flavopiridol: CDK Assays and ER-Stress Workflows
2026-08-24
Flavopiridol (L868275) combines broad CDK inhibition with practical utility in cell-cycle, apoptosis, transcription, and cancer research assays. This guide adapts an intestinal stem-cell ER-stress framework into controlled workflows for separating cytostasis, cell death, and pathway-specific responses.
-
Quercetin, Hippo Signaling, and Cataract Protection
2026-08-23
The reference study integrates network pharmacology with mouse and lens epithelial-cell experiments to examine how quercetin protects against cataract-associated damage. Its most important implication is that Hippo pathway suppression may connect antioxidant recovery with improved epithelial-cell survival, although the mechanism remains pharmacologically and clinically provisional.
-
SM-102 for mRNA LNP Workflow Optimization
2026-08-22
SM-102 supports reproducible lipid nanoparticle workflows for mRNA delivery, from ethanol stock preparation through encapsulation and cell-based expression testing. This practical guide combines bench-ready starting conditions with machine-learning insights to help researchers prioritize formulations and troubleshoot low potency, precipitation, and batch variability.
-
SM-102 Workflows for mRNA Delivery
2026-08-22
SM-102 provides a practical ionizable-lipid starting point for lipid nanoparticle formulation, with ethanol compatibility that simplifies stock preparation and screening. This guide connects bench-scale formulation, assay selection, comparative benchmarking, and machine-learning-informed optimization for mRNA vaccine and therapeutic research.
-
Cholesterol in mRNA-LNP Workflow Design
2026-08-21
Use Cholesterol as a controllable membrane component when optimizing mRNA-loaded lipid nanoparticles, membrane fluidity assays, and sterol-dependent cell models. This practical guide connects formulation screening with the localized p21 mRNA-LNP strategy reported for bladder cancer while separating published evidence from recommended starting conditions.
-
KX2-391 and KX2-361: Dual Src–Tubulin Inhibition
2026-08-20
The reference study describes a discovery strategy that produced KX2-391 and KX2-361, non-ATP-competitive Src inhibitors designed to engage the peptide-substrate site and later found to inhibit tubulin polymerization. Its findings connect substrate-site kinase design with dual-mechanism pharmacology, while also illustrating the evidence needed to move from molecular modeling to cellular and translational testing.
-
QX77 Molecular Chaperone Activator Workflows
2026-08-20
QX77 is a receptor-focused molecular chaperone activator for dissecting LAMP2A-dependent autophagy, Rab11-linked trafficking, and ES cell fate decisions. This practical guide connects fresh-solution handling and dose-finding workflows with mechanistic controls inspired by recent mitophagy research.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-08-19
Masitinib (AB1010) provides a DMSO-compatible approach for studying KIT, PDGFRα, and PDGFRβ inhibition in cancer, mast cell, and inflammatory disease models. It is not appropriate for aqueous or ethanol-based workflows, and product-dossier potency values should not be treated as universal cellular effective concentrations or clinical treatment guidance.
-
PD 173074: Precision FGFR Biology for Translation
2026-08-19
PD 173074 offers translational researchers a selective way to interrogate FGFR1 and VEGFR2 biology, connect kinase inhibition to angiogenesis and tumor phenotypes, and avoid overinterpreting multidrug-resistance findings that differ from broader FGFR inhibitors.
-
BKT140 (BL-8040) in CXCR4 Research
2026-08-18
Build more informative oncology experiments with BKT140 (BL-8040), moving from receptor expression to functional chemotaxis, apoptosis, and stem-cell mobilization readouts. This workflow emphasizes assay controls, formulation stability, and translational links to CXCR4-targeted lymphoma imaging.
-
D-Luciferin Potassium Salt: BLI Workflow Guide
2026-08-18
D-Luciferin potassium salt supports sensitive, ATP-dependent readouts from cultured cells to longitudinal animal studies. This guide connects practical in vivo bioluminescence imaging, luciferase reporter assay design, and plant-defense research while emphasizing controls, timing, and troubleshooting.
-
Okadaic acid (A4540): PP1/PP2A Workflow Guide
2026-08-17
Okadaic acid (A4540) provides a controlled way to reduce PP2A activity at lower nanomolar exposure and extend inhibition toward PP1 at higher exposure, supporting phosphorylation and apoptosis workflows. It is useful for defined biochemical and cell-based experiments, but should not be treated as a universal phosphatase blocker or as standalone proof of a specific apoptotic mechanism.
-
BMS 309403: FABP4 Inhibitor Research Workflows
2026-08-17
BMS 309403 provides a selective way to test how FABP4 connects fatty acid handling with macrophage inflammation, foam cell formation, and metabolic dysfunction. This practical guide translates recent SERCA2 pathway findings into cell-based workflows, assay controls, optimization steps, and translational research strategies.
-
Rocilinostat (ACY-1215) Assay Workflows
2026-08-16
Build selective HDAC6 experiments around α-tubulin acetylation, myeloma viability, and combination-response measurements. This guide also shows how to extend Rocilinostat assays into primary-cilia and neurodevelopmental models without overstating evidence from the SMPD4 study.
-
Eicosapentaenoic Acid (EPA) Research Workflows
2026-08-15
Build reproducible Eicosapentaenoic Acid experiments around two distinct concentration windows: low-micromolar lipid oxidation assays and approximately 100 μM endothelial migration studies. This practical guide also explains how to use EPA as a cardiovascular research tool without overextending arachidonic acid findings into unsupported immune claims.